Advances in radiotherapy for carcinoma of the head and neck

Surgical Oncology Clinics of North America

Volumn 9, Issue 3, 2000, Pages 563-575

  Morris, M M ^a   Schmidt Ullrich, R ^a   Johnson, C R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

CANCER CONTROL; COMPUTER ASSISTED RADIOTHERAPY; HEAD AND NECK CARCINOMA; RADIATION DOSE FRACTIONATION; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0033933363     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30140-6     Document Type: Review

References (61)

1. Adelstein D.J. Saxton J.P. Lavertu P. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results Head Neck 19 1997 567 575
2. Al-Sarraf M. LeBlanc M. Giri P.G.S. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099 J Clin Oncol 16 1998 1310 1317
3. Ang K.K. Peters L.J. Concomitant boost radiotherapy in the treatment of head and neck cancers Semin Radiat Oncol 2 1992 31 33
4. Bentzen S.M. Thames H.D. Clinical evidence for tumor clonogen regeneration: Interpretations of the data Radiother Oncol 22 1991 161 166
5. Brizel D.M. Albers M.E. Fisher S.R. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
6. Cardinale R.M. Kavanagh B.D. Conformal radiotherapy: What is it and why does it matter? Surg Oncol Clin North Am 9 2000 415 434
7. Carter S. Auer K.L. Birrer M. Inhibition of the mitogen-activated protein kinase cascade potentiates cell killing by lose dose radiation in A431 human squamous carcinoma cells Oncogene 16 1998 2787 2796
8. Datta N.R. Choudhry A.D. Gupta S. Twice a day versus once a day radiation therapy in head and neck cancer Int J Radiat Oncol Biol Phys 17 1989 132
9. Denekamp J. Changes in the rate of repopulation during multi-fraction irradiation of mouse skin Br J Radiol 46 1973 381 392
10. Dische S. Saunders M. Barrett A. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
11. Eisbruch A. Marsh L.A. Martel M.K. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and noninvolved tissue sparing Int J Radiat Oncol Biol Phys 41 1998 559 568
12. El-Sayed S. Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847
13. Emami B. Purdy J.A. Simpson J.A. 3D Conformal radiotherapy in head and neck cancer The Washington University experience 29 1996 207 220
14. Forastiere A.A. Randomized trials of induction chemotherapy: A critical review Hematol Oncol Clin North Am 5 1991 725 736
15. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
16. Fowler J.F. Lindstrom M.H. Loss of local control with prolongation in radiotherapy Int J Radiat Oncol Biol Phys 23 1992 457 467
17. Fu K.K. Clery M. Ang K.K. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09 Int J Radiat Oncol Biol Phys 32 1995 589 597
18. Fu K.K. Pajak T.F. Trotti A. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionated and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003 Int J Radiat Oncol Biol Phys 45 S1 1999 145
19. Fu K.K. Phillips T.L. Silverberg I.J. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial J Clin Oncol 5 1987 1410 1418
20. Garden A.S. Glisson B.S. Ang K.K. Phase I/II trial of radiation with chemotherapy “boost” for advanced squamous cell carcinoma of the head and neck: Toxicities and responses J Clin Oncol 17 1999 2390 2395
21. Garden A.S. Morrison W.H. Ang K.K. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: A comparison of two fractionation schedules Int J Radiat Oncol Biol Phys 31 1995 493 502
22. Glisson B.S. Hong W.K. Primary chemotherapy of advanced head and neck cancer: Where do we go from here? [editorial] J Natl Cancer Inst 88 1996 567 568
23. Gupta N.K. Pointon R.C. Wilkinson P.M. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer Clin Radiol 38 1987 575 581
24. Haffty B.G. Son Y.H. Papac R. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials J Clin Oncol 15 1997 268 276
25. Hall E.J. Time, dose, and fractionation in radiotherapy Radiobiology for the Radiologist ed 4 1994 JB Lippincott Philadelphia 211 229
26. Hazuka M.B. Turrisi A.T. Lutz S.T. Results of high-dose thoracic irradiation incorporating beam’s eye view display in non-small cell lung cancer: A retrospective multivariate analysis Int J Radiat Oncol Biol Phys 27 1993 273 284
27. Hendry J.H. Roberts S.A. Slevin N.J. Influence of radiotherapy treatment time on control of laryngeal cancer: Comparisons between centres in Manchester, UK and Toronto, Canada Radiother Oncol 31 1994 14 21
28. Horiot J.C. Bontempts P. van den Bogaert V. Accelerated fractionation (AF) compared to conventional fractionation (CF) improved head and neck cancers: Results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121
29. Horiot J.C. Le Fur R.N. Guyen T. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241
30. Huang S.M. Bock J.M. Harari P.M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis and radiosensitivity in squamous cell carcinomas of the head and neck Cancer Res 59 1999 1935 1940
31. Kasid U. Suy S. Dent P. Activation of Raf by ionizing radiation Nature 382 1996 813 816
32. Kavanagh B.D. Dent P. Schmidt-Ullrich R.K. Calcium-dependent stimulation of MAP-kinase activity in A431 cells by low doses of ionizing radiation Radiat Res 149 1998 579 587
33. Leibel S.A. Kutcher G.J. Harrison L.B. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx Int J Radiat Oncol Biol Phys 20 1991 823 833
34. Maciejewski B. Withers H.R. Taylor J.M.G. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation Int J Radiat Oncol Biol Phys 16 1989 831 843
35. McKenna W.G. Weiss M.C. Makanauskas V.J. The role of the H-ras oncogene in radiation resistance and metastasis Int J Radiat Oncol Biol Phys 18 1990 849 859
36. Meeks S.L. Buatti J.M. Bova F.J. Potential clinical efficacy of intensity-modulated conformal therapy Int J Radiat Oncol Biol Phys 40 1998 483 495
37. Merlano M. Benasso M. Corvo R. Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583 589
38. Mohan R. Wang X. Jackson A. The potential and limitations of the inverse radiotherapy technique Radiother Oncol 32 1994 232 248
39. Mohan R. Wu Q. Wang X-H Intensity modulation optimization, lateral transport of radiation and margins Med Phys 23 1996 2011 2022
40. Morrison W.H. Garden A.S. Ang K.K. Long term results of the concomitant boost fractionation schedule for treatment of oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 45 S1 1999 197 198
41. Overgaard J. Hansen H.S. Sapru W. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck: A randomized multicenter study of 5 versus 6 fractions per week: Preliminary report from DAHANCA 6 and 7 trials Radiother Oncol 40 1996 S31
42. Parsons J.T. Mendenhall W.M. Cassissi N.J. Hyperfractionation for head and neck cancer Int J Radiat Oncol Biol Phys 14 1988 649 658
43. Parsons J.T. Mendenhall W.M. Million R.R. Twice-a-day irradiation of squamous cell carcinoma of the head and neck Semin Radiat Oncol 2 1992 29 30
44. Peracchia G. Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experience Int J Radiat Oncol Biol Phys 7 1981 99 104
45. Peters L.J. Accelerated fractionation using the concomitant boost: A contribution of radiobiology to radiotherapy Br J Radiol S24 1992 200 203
46. Pinto L. Canary P. Araujo C. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 21 1991 557 562
47. Schmidt-Ullrich R.K. Johnson C.R. Wazer D.E. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: Concomitant boost technique Int J Radiat Oncol Biol Phys 21 1991 563 568
48. Schmidt-Ullrich R.K. Mikkelsen R.B. Dent P. Radiation-induced proliferation of human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation Oncogene 15 1997 1191 1197
49. Schmidt-Ullrich R.K. Valerie K. Chan W. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures Int J Radiat Oncol Biol Phys 29 1994 813 819
50. Sham E. Durand R.E. Cell kinetics and repopulation mechanisms during multifraction irradiation of spheroids Radiother Oncol 46 1998 201 207
51. Thames H.D. Bentzen S.M. Turesson I. Time-dose factors in radiotherapy: A review of the human data Radiother Oncol 19 1990 219 235
52. Thames H.D. Withers H.R. Peters L.J. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships Int J Radiat Oncol Biol Phys 8 1982 219 226
53. Verhey L.J. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems Semin Radiat Oncol 9 1999 78 98
54. Vokes E.E. Weichselbaum R.R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors J Clin Oncol 8 1990 911 934
55. Wang C.C. Blitzer P.H. Suit H.D. Twice-a-day radiation therapy for cancer of the head and neck Cancer 55 1985 2100 2104
56. Wang C.C. Efird J. Nakfoor B. Local control of T3 carcinomas after accelerated fractionation: A look at the “gap.” Int J Radiat Oncol Biol Phys 35 1996 439 441
57. Wendt C.D. Peters L.J. Ang K.K. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx Int J Radiat Oncol Biol Phys 17 1989 1057 1061
58. Withers H.R. Treatment-induced accelerated human tumor growth Semin Radiat Oncol 3 1993 135 143
59. Withers H.R. McBride W.H. Radiation effects on normal tissues Front Radiat Ther Oncol 32 1999 1 8
60. Withers H.R. Taylor J.M.G. Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
61. Wu Q. Schmidt-Ullrich R. Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A case study Int J Radiat Oncol Biol Phys 46 2000 195 205